Neumora (NMRA) Fundamental Analysis: Revenue, Earnings & Valuation

6.54 / 10

Outperform

Fundamental analysis rates NMRA as Outperform with a 6.5/10 quality score. Strong points include inventory turnover, receivables efficiency, and PB‑ROE, while fixed‑asset turnover and revenue‑MV are weaker. Overall fund‑flow‑adjusted score is 6.54, indicating moderate upside.

Analysis Checks(8/10)

Revenue-MV

Value-0.28

Score3/3

Weight29.78%

1M Return8.83%

Total operating revenue (YoY growth rate %)

Value78.05

Score2/3

Weight1.58%

1M Return0.58%

Inventory turnover ratio

Value47.57

Score3/3

Weight-1.69%

1M Return-0.67%

Accounts receivable turnover ratio

Value25.89

Score2/3

Weight-1.67%

1M Return-0.65%

PB-ROE

Value0.59

Score3/3

Weight43.07%

1M Return12.56%

Income tax / Total profit (%)

Value-0.07

Score1/3

Weight-1.53%

1M Return-0.59%

Fixed assets turnover ratio

Value7899.90

Score1/3

Weight-3.14%

1M Return-1.28%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-1.89%

1M Return-0.73%

Cost of sales ratio (%)

Value70.30

Score2/3

Weight-1.85%

1M Return-0.74%

Asset-MV

Value-0.48

Score2/3

Weight37.35%

1M Return9.91%

Is NMRA fundamentally strong?

NMRA scores 6.54/10 on fundamentals and holds a Discounted valuation at present. Backed by its -84.67% ROE, 0.00% net margin, -1.57 P/E ratio, 3.00 P/B ratio, and -22.50% earnings growth, these metrics solidify its Outperform investment rating.